Fujifilm and Bayer to jointly develop new cancer therapy

Business / Corporate Jul 2, 2019

Fujifilm and Bayer to jointly develop new cancer therapy

Fujifilm Corp. has said it will team up with Germany's Bayer AG on the development of a new immune-based cancer therapy platform using induced pluripotent stem, or iPS, cells that come from someone other than the patient. The German pharmaceutical giant will join the development ...